This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Medics transfer a patient on a stretcher from an ambulance outside of Emergency at Coral Gables Hospital where coronavirus patients are treated in Coral Gables near Miami, Fla., on Aug. 16, 2021. Chandan Khanna/AFP via Getty Images
MINNEAPOLIS—A subset of COVID-19 patients who received infusions of laboratory-made antibodies ran a lower risk of requiring hospital care for their illnesses, according to a Mayo Clinic study released Monday.
